Non profit foundation
Born in January 2022
Developing projects to give visibility to the Retinitis Pigmentosa
Raising funds to help the medical research
HORIZON FOUNDATION was created with aim of raising funds to help the medical research of
In an attempt to finally find the solution that could put an end to long years of research into a potential treatment to cure Retinitis Pigmentosa, we decided to create Horizon Foundation.
This foundation aims to help the Institut de la Vision de Paris, by carrying out numerous projects around sailing and fashion, and to seek great media coverage to give it a maximum visibility and raise as much funds as possible to give the possibility of creating new treatment protocols or new clinical trials.
Bringing light and awareness to Retinopathy Pigmentosa
Inform about recent medical advances
Mediate the disease through
Create unique content with a unique storytelling
Raising funds to help medical research
Help people with eyes diseases with the hope of healing them and restoring sight to those who have lost it
How do we work & how do we help medical research ?
We will raise funds with this ongoing project :
We work as follows :
Clients contact us with the aim of producing and carrying out their next advertising campaign,
We establish a production shoot and send you an estimate for the realization.
The customer makes a donation of his choice to Horizon Foundation.
As a reminder, 70% is donated directly to the Institut de la Vision de Paris and 30% remains with us to develop the Foundation.
We work most of the time with Clement as a photographer who works essentially in digital.
Borja, a great enthusiast and connoisseur of the legendary camera Bolex, is filming everything in analog (16mm).
Beltran takes care of all the realization.
A preview of the rendering, for example when making a video for Giorgio Armani :
With our research teams, we are convinced that the call for donations, associated with strong media coverage of the HORIZON foundation through their various projects and the international reputation of the companies with which they collaborate, would be a great way to contribute together to the culmination of research projects on retinopathy pigmentosa and to communicate on our recent advances that bring so much hope.
Director of Institut de la Vision